Cargando…
A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma
HOXD1, HOXD3, and HOXD4 are members of the HOXD genes family and are related to tumorigenesis of the tumor. However, whether HOXDs (1, 3, 4) have a crucial role across pan-cancer is still unknown. HOXD1, HOXD3, and HOXD4 expressions were analyzed using public databases in 33 types of tumors. The UCS...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599751/ https://www.ncbi.nlm.nih.gov/pubmed/37827698 http://dx.doi.org/10.18632/aging.205116 |
_version_ | 1785125833611935744 |
---|---|
author | Wang, Lumin Wang, Xiaofei Sun, Haifeng Wang, Wenjing Cao, Li |
author_facet | Wang, Lumin Wang, Xiaofei Sun, Haifeng Wang, Wenjing Cao, Li |
author_sort | Wang, Lumin |
collection | PubMed |
description | HOXD1, HOXD3, and HOXD4 are members of the HOXD genes family and are related to tumorigenesis of the tumor. However, whether HOXDs (1, 3, 4) have a crucial role across pan-cancer is still unknown. HOXD1, HOXD3, and HOXD4 expressions were analyzed using public databases in 33 types of tumors. The UCSC Xena website was carried out to investigate the relationship between the expression of genes and the progress of cancers. The biological functions of HOXD3 were tested by colony forming, transwell, wound healing, and xenograft assay in vitro and in vivo. GSEA was used to identify the associated cancer hallmarks with HOXDs expression. Immune cell infiltration analysis was applied to verify the immune cell infiltrations related to genes. The results showed HOXD1, HOXD3, and HOXD4 co-low expressed in BRCA, COAD, KICH, KIRC, KIRP, READ, and TGCT. In the KIRC, all of HOXDs expression was connected with tumor stage and histological grade. Upregulation of HOXDs was associated with improved OS, DSS, and PFI. Down-expression of HOXD3 induced cell proliferation, migration, and invasion in vivo and in vitro. In addition, HOXDs were connected with immune-activated hallmarks and cancer immune cell infiltrations. These findings demonstrated that HOXDs may be indicative biomarkers for the prognosis and immunotherapy in pan-cancer. |
format | Online Article Text |
id | pubmed-10599751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-105997512023-10-26 A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma Wang, Lumin Wang, Xiaofei Sun, Haifeng Wang, Wenjing Cao, Li Aging (Albany NY) Research Paper HOXD1, HOXD3, and HOXD4 are members of the HOXD genes family and are related to tumorigenesis of the tumor. However, whether HOXDs (1, 3, 4) have a crucial role across pan-cancer is still unknown. HOXD1, HOXD3, and HOXD4 expressions were analyzed using public databases in 33 types of tumors. The UCSC Xena website was carried out to investigate the relationship between the expression of genes and the progress of cancers. The biological functions of HOXD3 were tested by colony forming, transwell, wound healing, and xenograft assay in vitro and in vivo. GSEA was used to identify the associated cancer hallmarks with HOXDs expression. Immune cell infiltration analysis was applied to verify the immune cell infiltrations related to genes. The results showed HOXD1, HOXD3, and HOXD4 co-low expressed in BRCA, COAD, KICH, KIRC, KIRP, READ, and TGCT. In the KIRC, all of HOXDs expression was connected with tumor stage and histological grade. Upregulation of HOXDs was associated with improved OS, DSS, and PFI. Down-expression of HOXD3 induced cell proliferation, migration, and invasion in vivo and in vitro. In addition, HOXDs were connected with immune-activated hallmarks and cancer immune cell infiltrations. These findings demonstrated that HOXDs may be indicative biomarkers for the prognosis and immunotherapy in pan-cancer. Impact Journals 2023-10-12 /pmc/articles/PMC10599751/ /pubmed/37827698 http://dx.doi.org/10.18632/aging.205116 Text en Copyright: © 2023 Wang et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Wang, Lumin Wang, Xiaofei Sun, Haifeng Wang, Wenjing Cao, Li A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma |
title | A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma |
title_full | A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma |
title_fullStr | A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma |
title_full_unstemmed | A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma |
title_short | A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma |
title_sort | pan-cancer analysis of the role of hoxd1, hoxd3, and hoxd4 and validation in renal cell carcinoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599751/ https://www.ncbi.nlm.nih.gov/pubmed/37827698 http://dx.doi.org/10.18632/aging.205116 |
work_keys_str_mv | AT wanglumin apancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT wangxiaofei apancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT sunhaifeng apancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT wangwenjing apancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT caoli apancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT wanglumin pancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT wangxiaofei pancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT sunhaifeng pancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT wangwenjing pancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma AT caoli pancanceranalysisoftheroleofhoxd1hoxd3andhoxd4andvalidationinrenalcellcarcinoma |